Remove Dosage Remove Insurance Coverage and Processing Remove Presentation
article thumbnail

State of Well-Being 2023-2024

The Happy PharmD

This annual report presents insights gleaned from over 79,000 Well-Being Index assessments conducted in 2023, with a particular emphasis on the 2,584 assessments completed by pharmacists. Or perhaps it’s the constant back-and-forth with insurance companies over coverage? Share your thoughts down below!

article thumbnail

MTHFR, Hashimoto’s and Nutrients

The Thyroid Pharmacist

In fact, it’s present in up to 55 percent of the European population, is naturally occurring, and often has no negative health consequences – unless expressed. [1] Unfortunately, synthetic folic acid can be highly problematic for individuals with the MTHFR gene variation, as they may have a difficult time processing this form of folate.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top Performing Drug – Trikafta/Kaftrio (May Edition)

PharmaShots

The report is concluded with an engaging SWOT analysis and edifying KOL reviews Active Ingredient: (elexacaftor, tezacaftor, and ivacaftor tablets, ivacaftor tablets) Dosage Forms & Strengths: Tablets: fixed-dose combination containing elexacaftor 100 mg, tezacaftor 50 mg, and ivacaftor 75 mg.

article thumbnail

Finding Your Root Cause: Key Lab Tests

The Thyroid Pharmacist

I’ll specify which tests are usually covered on insurance if you have a willing practitioner that can bill insurance, which tests can be self-ordered and then submitted to insurance, and which ones are usually an out-of-pocket expense that you may need to save for. You can use Health Savings Accounts for most.)

article thumbnail

Top Performing Drug – Enbrel (June Edition)

PharmaShots

Revenue Analysis1 PharmaShots presents a 5-year analysis of Enbrel sales. Before we deep dive into its sales analysis of each year, let us first look at how this product was launched and its related collaborations. The stacked column chart below is a visual representation of the clinical trials conducted with Enbrel so far.